Ignite Creation Date:
2025-12-24 @ 2:11 PM
Ignite Modification Date:
2026-02-20 @ 10:08 PM
Study NCT ID:
NCT00348595
Status:
COMPLETED
Last Update Posted:
2019-04-12
First Post:
2006-06-30
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of 2 Different Doses of Revlimid in Biochemically Relapse Prostate Cancer
Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-07-20
Start Date Type:
ACTUAL
Primary Completion Date:
2016-06-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-06-29
Completion Date Type:
ACTUAL
First Submit Date:
2006-06-30
First Submit QC Date:
None
Study First Post Date:
2006-07-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-03-21
Results First Submit QC Date:
None
Results First Post Date:
2019-04-12
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-04-11
Last Update Post Date:
2019-04-12
Last Update Post Date Type:
ACTUAL